Skip to main content

Gram-positive nosocomial infections in a general ICU: emerging new clues

Introduction

Gram-positive aerobes are currently the leading cause of infection in many ICUs. Despite this trend, there are still no firm recommendations for empiric Gram-positive antimicrobial coverage in patients with severe nosocomial infections. The current study is an extension of our previous work in this field, aiming to challenge some of the earlier trends and to bring out new clues.

Methods

A prospective observational study was conducted including all episodes of documented nosocomial infection in a general ICU for a 4-year period (2006 to 2009). Data on demographics, primary diagnosis, co-morbidity, number of indwelling devices, previous microbial isolates and current antibiotics were cross-tabulated according to the presence and type of Gram-positive pathogens. For the identified most likely risk factors, separate contingency tables were constructed and analyzed.

Results

A total of 339 patients with Gram-positive isolates were identified (51.21% of 662). Gram-positive isolates were more prevalent in patients with obesity (1.27; CI = 1.08 to 1.47) and diabetes (1.28; CI = 1.03 to 1.53). The following independent risk factors for Gram-positive nosocomial infections (RR and 95% CI) were identified: MRSE-gunshot wound (4.18; 2.35 to 5.19), stab wound (4.01; 2.03 to 4.59), polytrauma (1.91; 1.47 to 2.46), previous isolation of both Acinetobacter spp. and Pseudomonas or Candida spp. (2.01; 1.38 to 2.72 and 2.72; 1.71 to 4.21), treatment with aminoglycoside or carbapenem (2.52; 1.59 to 3.42 and 1.37; 1.03 to 1.80); Enterococcus - billiary peritonitis (2.23; 1.27 to 3.73), acute necrotizing pancreatitis (2.23; 1.27 to 3.73), traumatic lesion of urinary bladder with cystostomy (6.68; 3.26 to 9.65), previous isolation of both Klebsiella and Candida spp. (6.02; 1.85 to 9.40), treatment with cefoperazone + sulbactam or third-generation cephalosporin (3.49; 2.18 to 5.34 and 1.87; 1.17 to 2.92); MRSA - clinical uroinfection (5.27; 1.74 to 13.52), previous isolation of both Acinetobacter and Pseudomonas spp. (4.21; 1.79 to 9.42); MSSE - treatment with first/second/third-generation cephalosporin ± metronidazole (5.88; 1.84 to 17.16 and 4.65; 1.71 to 12.18); Streptococcus - pelvic inflammatory disease (5.10; 1.35 to 15.75), soft tissue infection (8.32; 2.73 to 45.36), treatment with quinolones (3.45; 1.34 to 8.54).

Conclusions

New light was shed on the identification of associated risk factors for Gram-positive nosocomial infections in our ICU. Sufficient data were gathered to aid empirical antibiotic choice in such high-risk patients.

Author information

Affiliations

Authors

Corresponding author

Correspondence to S Milanov.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Milanov, S., Georgiev, G., Todorova, V. et al. Gram-positive nosocomial infections in a general ICU: emerging new clues. Crit Care 15, P224 (2011). https://doi.org/10.1186/cc9644

Download citation

Keywords

  • Nosocomial Infection
  • Carbapenem
  • Pelvic Inflammatory Disease
  • Cefoperazone
  • Sulbactam